Table 2 Main features in the four groups. Statistical analysis in the last column
Non-Existent N = 43 | Scarce N = 40 | Moderate N = 35 | Abundant N = 34 | Significance among groups | |
|---|---|---|---|---|---|
Age (mean, SD) | 71.84 (SD 1.89) | 74.60 (SD 1.65) | 70.77 (SD 1.59) | 77.71 (SD 1.51) | p = 0.13a |
Male sex (number, %) | 23 (53.5%) | 19 (47.5%) | 24 (68.6%) | 15 (44.1%) | p = 0.174b |
Snellen VA (n, SD) | 0.32 (SD 0.03) | 0.44 (SD 0.4) | 0.92 (0.44) | 0.34 (SD 0.04) | p = 0.084a |
Pathology (n, %) | p = 0.243b | ||||
AMD | 19 (44.2%) | 27 (67.5%) | 19 (54.3%) | 20 (58.8%) | |
RVO | 5 (11.6%) | 6 (15%) | 7 (20%) | 8 (23.5%) | |
DME | 9 (20.9%) | 5 (12.5%) | 6 (17.1%) | 4 (11.3%) | |
Myopia | 2 (4.6%) | 1 (2.5%) | 0 (0%) | 1 (2.8%) | |
Other | 8 (18.6%) | 1 (2.5%) | 3 (8.6%) | 1 (2.8%) | |
PVD Present (n, %) | 27 (62.8%) | 19 (47.5%) | 24 (68.6%) | 30 (88.2%) | p = 0.003b |
IOP (mean, SD) | 15.21 (SD 0.515) | 16.05 (SD 0.765) | 14.63 (SD 0.499) | 18.68 (SD 2.94) | p = 0.259a |
Follow-up time in months (mean, SD) | 27.79 (SD 4.97) | 36.05 (4.61) | 39.03 (5.4) | 37.32 (SD 4.83) | p = 0.066a |